Suppr超能文献

引入β-发夹序列基序以提高基于肽的PROTAC的细胞内稳定性。

Incorporating a β-hairpin sequence motif to increase intracellular stability of a peptide-based PROTAC.

作者信息

Hymel Hannah C, Anderson Jeffery C, Liu Dong, Gauthier Ted J, Melvin Adam T

机构信息

Cain Department of Chemical Engineering, Louisiana State University, Baton Rouge, LA, 70803.

LSU AgCenter Biotechnology Lab, Louisiana State University, Baton Rouge, LA 70803.

出版信息

Biochem Eng J. 2023 Oct;199. doi: 10.1016/j.bej.2023.109063. Epub 2023 Aug 9.

Abstract

Proteolysis targeting chimeras (PROTACs) have emerged as a new class of therapeutics that utilize the ubiquitin-proteasome system (UPS) to facilitate proteasomal degradation of "undruggable" targets. Peptide-based PROTACs contain three essential components: a binding motif for the target protein, a short amino acid sequence recognized by an E3 ligase called a degron, and a cell penetrating peptide to facilitate uptake into intact cells. While peptide-based PROTACs have been shown to successfully degrade numerous targets, they have often been found to exhibit low cell permeability and high protease susceptibility. Prior work identified peptides containing a β-hairpin sequence motif that function not only as protecting elements, but also as CPPs and degrons. The goal of this study was to investigate if a β-hairpin sequence could replace commonly used unstructured peptides sequences as the degron and the CPP needed for PROTAC uptake and function. The degradation of the protein Tau was selected as a model system as several published works have identified a Tau binding element that could easily be conjugated to the β-hairpin sequence. A series of time- and concentration-dependent studies confirmed that the βhairpin sequence was an adequate alternative CPP and degron to facilitate the proteasomemediated degradation of Tau. Microscopy studies confirmed the time-dependent uptake of the PROTAC and a degradation assay confirmed that the β-hairpin conjugated PROTAC had a greater lifetime in cells.

摘要

蛋白酶靶向嵌合体(PROTACs)已成为一类新型治疗药物,它利用泛素-蛋白酶体系统(UPS)促进“不可成药”靶点的蛋白酶体降解。基于肽的PROTACs包含三个基本成分:靶蛋白的结合基序、一种被称为降解子的能被E3连接酶识别的短氨基酸序列,以及一种细胞穿透肽以促进其被完整细胞摄取。虽然基于肽的PROTACs已被证明能成功降解众多靶点,但人们经常发现它们表现出低细胞通透性和高蛋白酶敏感性。先前的研究确定了含有β-发夹序列基序的肽,其不仅作为保护元件起作用,还作为细胞穿透肽和降解子起作用。本研究的目的是调查β-发夹序列是否可以取代常用的无结构肽序列,作为PROTAC摄取和发挥功能所需的降解子和细胞穿透肽。选择蛋白质Tau的降解作为模型系统,因为一些已发表的研究确定了一个Tau结合元件,它可以很容易地与β-发夹序列偶联。一系列时间和浓度依赖性研究证实,β-发夹序列是一种合适的替代细胞穿透肽和降解子,可促进蛋白酶体介导的Tau降解。显微镜研究证实了PROTAC的时间依赖性摄取,降解试验证实了与β-发夹偶联的PROTAC在细胞中的寿命更长。

相似文献

6
PROTAC-DB 2.0: an updated database of PROTACs.PROTAC-DB 2.0:一个更新的 PROTAC 数据库。
Nucleic Acids Res. 2023 Jan 6;51(D1):D1367-D1372. doi: 10.1093/nar/gkac946.

本文引用的文献

2
PROTAC Degrader of Estrogen Receptor α Targeting DNA-Binding Domain in Breast Cancer.靶向乳腺癌雌激素受体α DNA结合结构域的PROTAC降解剂
ACS Pharmacol Transl Sci. 2022 Oct 12;5(11):1109-1118. doi: 10.1021/acsptsci.2c00109. eCollection 2022 Nov 11.
4
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope.非小分子PROTAC(NSM-PROTAC):蛋白质降解万花筒
Acta Pharm Sin B. 2022 Jul;12(7):2990-3005. doi: 10.1016/j.apsb.2022.02.022. Epub 2022 Feb 26.
5
PROTACs: past, present and future.PROTACs:过去、现在和未来。
Chem Soc Rev. 2022 Jun 20;51(12):5214-5236. doi: 10.1039/d2cs00193d.
10
An E3 ligase guide to the galaxy of small-molecule-induced protein degradation.一种 E3 连接酶引导的小分子诱导蛋白降解的星系。
Cell Chem Biol. 2021 Jul 15;28(7):1000-1013. doi: 10.1016/j.chembiol.2021.04.002. Epub 2021 Apr 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验